Level Double-A conformance icon, W3C-WAI Web Content Accessibility Guidelines 1.0

Valid HTML 4.01

Valid CSS

IIAC Press Release - 3rd July 2007

Appointment Of A New Chairman To The Industrial Injuries Advisory Council

It has been announced that Dr Keith Palmer will take up the post of Chairman of the Industrial Injuries Advisory Council (IIAC). He will take up the role on 18 January 2008 when the current Chairman, Professor Anthony Newman Taylor, retires from the post.

Dr Palmer is a clinical scientist at the Medical Research Council Epidemiology Research Centre, University of Southampton, and an honorary consultant occupational physician with the Southampton University NHS Trust.

He is also Academic Dean, Faculty of Occupational Medicine, Royal College of Physicians, and Editor-in-Chief of the BMJ Publishing Group journal Occupational and Environmental Medicine. The University of Southampton has conferred on him the honorary title Professor of Occupational Medicine with effect from 1st September 2007.

The IIAC is a statutory, scientific advisory body, which advises the Secretary of State for Work and Pensions on occupational diseases in the context of the Industrial Injuries Disablement Benefit (IIDB) Scheme.

Notes to editors

  1. The Industrial Injuries Advisory Council is an independent body which advises the Secretary of State for Work and Pensions on the Industrial Injuries Disablement Benefit Scheme which provides weekly compensation for people injured at work because of industrial accidents and prescribed diseases.
  2. Role of the Industrial Injuries Advisory Council
    The Industrial Injuries Advisory Council is an independent statutory body set up in 1946 to advise the Secretary of State for Work and Pensions on matters relating to the Industrial Injuries Disablement Benefit Scheme. The majority of the Council's time is spent considering whether the list of prescribed diseases for which benefit may be paid should be enlarged or amended.
  3. The Council's Research Working Group meets quarterly to review new scientific evidence about diseases which they are monitoring and other diseases where new evidence of a possible occupational link requires consideration.
  4. Composition of the Council:
    The Council currently has 16 members including the chairman. It consists of medical specialists, epidemiologists, and legal experts, and, by statute, an equal number of employers’ and employees’ representatives (currently 4 each). Appointments are made to the Council by the Secretary of State following an open selection procedure under the guidance of the Office of the Commissioner for public Appointments.
  5. The Council's remit:
    The Council has three roles:
    • to advise on the prescription of industrial diseases
    • to advise on Regulations under the Social Security Administration Act 1992 and the Contributions and Benefits Act 1992
    • to advise on the Industrial Injuries Disablement Benefit Scheme itself.
  6. Legal requirements for prescription of diseases
    The Social Security Contributions and Benefits Act 1992 states that the Secretary of State may prescribe a disease where he is satisfied that the disease:
    1. ought to be treated, having regard to its causes and incidence and any other relevant considerations, as a risk of the occupation and not as a risk common to all persons; and
    2. is such that, in the absence of special circumstances, the attribution of particular cases to the nature of the employment can be established or presumed with reasonable certainty.
  7. In other words, a disease may only be prescribed if there is a recognised risk to workers in an occupation, and the link between disease and occupation can be established or reasonably presumed in individual cases. The Council looks for a workable definition of the disease and a practical way in which demonstrate in the individual case that the disease can be attributed to occupational exposure with reasonable confidence. There are two ways in which a disease can be attributed to occupation with reasonable confidence – clinical features or epidemiological evidence of a doubling of risk. Clinical features of a disease may allow attribution to occupation in some cases, e.g. an employee’s dermatitis may improve when they are away from work. In the case of doubling of risk, the Council looks for epidemiological evidence that the disease is twice as likely to occur in that occupation compared to the general population. The Council makes decisions based on robust evidence, typically from different sources and with a sound scientific basis.